Manuela Buzoianu

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin α_vβ₃, ± dacarbazine in patients with stage IV metastatic melanoma

Peter Hersey, Jeffrey A. Sosman, Steven O’Day et al. · Cancer · 2010 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

HLA-Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction

Alin Girnita, René J. Duquesnoy, Samuel A. Yousem et al. · American Journal of Transplantation · 2005 · 166 citations · Full text

Life Sciences, Immunology, Autoimmunity +16

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors

Christina M. Annunziata, Elise C. Kohn, Patricia LoRusso et al. · Investigational New Drugs · 2012 · 117 citations · Full text

Pharmacy, Oncology, Pharmacology +16

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL)

Alan S. Wayne, Deepa Bhojwani, Lewis B. Silverman et al. · Blood · 2011 · 57 citations

Medicine, Immunology, Oncology +16

Adjusting for verification bias in diagnostic test evaluation: A Bayesian approach

Manuela Buzoianu, Joseph B. Kadane · Statistics in Medicine · 2007 · 29 citations · Full text

Public Health, Biostatistics, Bayesian Biostatistics +11